Clinical Trials Logo

Clinical Trial Summary

Liver fibrosis screening is possible at the asymptomatic stage through a healthcare management strategy currently recommended for patients with risk factors for chronic liver disease. It is based on a sequential strategy involving a 1st-line test, fibrosis score calculation (FIB-4). Given this opportunity to identify advanced fibrosis in asymptomatic patients, the project aims to set up this screening program in the Grenoble area with Biogroup Laboratories, in collaboration with the Hepato-gastroenterology department (HGE) of Grenoble University Hospital. The aim of this study is to evaluate the success of sequential screening using FIB-4, followed by a specialized fibrosis test for the diagnosis of advanced hepatic fibrosis


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06119997
Study type Observational
Source University Hospital, Grenoble
Contact
Status Not yet recruiting
Phase
Start date July 1, 2024
Completion date April 30, 2027

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02446665 - Disease Status in Primary Sclerosing Cholangitis by Elastography N/A
Completed NCT01447667 - Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) N/A
Recruiting NCT06062108 - Prevalence of Pain in Hospitalized Cirrhotic Patients
Completed NCT02138253 - A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Phase 2
Not yet recruiting NCT05871749 - Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
Completed NCT02372682 - Shear Wave Sonoelastography in Pediatric Liver Fibrosis
Completed NCT02958592 - Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study N/A
Completed NCT02031913 - Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
Completed NCT00466336 - Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices N/A
Recruiting NCT06252272 - Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis N/A
Recruiting NCT01783314 - Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium Phase 4
Completed NCT00466271 - Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study N/A
Completed NCT05383456 - The Visceral Adiposity Measurement and Observation Study